The role of Geriatric screening tool (G8) in predicting side effect in older patients during therapy with aromatase inhibitor.

Affiliation

Institute of Oncology, Policlinico di Monza, Monza, Italy. Electronic address: [Email]

Abstract

Endocrine therapy is the main treatment in hormonosensitive breast cancer; the most frequent side effects are arthralgia, osteoporosis, depression, dyslipidemia and hypertension. G8 is a simple test developed to identify older patients who could benefit from a comprehensive geriatric assessment (CGA). The aim of this study is to evaluate the possible role of G8 in predicting side effects from treatment with aromatase inhibitor in women ≥65 years old.

Keywords

Aromatase inhibitor,Breast cancer,G8,Geriatric assessment,Screening tool,